Unum Group (NYSE:UNM) is D. Scott Neal Inc.’s 3rd Largest Position

D. Scott Neal Inc. lessened its holdings in Unum Group (NYSE:UNM) by 3.3% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 280,877 shares of the financial services provider’s stock after selling 9,596 shares during the period. Unum Group accounts for approximately 11.3% of D. Scott Neal Inc.’s portfolio, making the stock its 3rd largest holding. D. Scott Neal Inc.’s holdings in Unum Group were worth $20,512,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Capital Performance Advisors LLP acquired a new position in shares of Unum Group during the 3rd quarter worth approximately $31,000. Thurston Springer Miller Herd & Titak Inc. purchased a new position in Unum Group during the third quarter worth $37,000. V Square Quantitative Management LLC raised its holdings in shares of Unum Group by 38.2% in the third quarter. V Square Quantitative Management LLC now owns 702 shares of the financial services provider’s stock worth $42,000 after acquiring an additional 194 shares during the last quarter. William B. Walkup & Associates Inc. acquired a new position in shares of Unum Group in the second quarter worth $44,000. Finally, Quarry LP lifted its position in shares of Unum Group by 4,794.7% in the third quarter. Quarry LP now owns 930 shares of the financial services provider’s stock valued at $55,000 after acquiring an additional 911 shares in the last quarter. 86.57% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

UNM has been the subject of a number of recent research reports. Jefferies Financial Group lifted their price objective on Unum Group from $91.00 to $96.00 and gave the stock a “buy” rating in a research report on Tuesday, December 10th. Piper Sandler boosted their price objective on shares of Unum Group from $74.00 to $82.00 and gave the company an “overweight” rating in a research report on Wednesday, December 18th. Truist Financial upped their price objective on shares of Unum Group from $70.00 to $75.00 and gave the company a “buy” rating in a research note on Friday, November 1st. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $79.00 target price (up from $74.00) on shares of Unum Group in a research note on Tuesday, January 7th. Finally, Barclays increased their price target on Unum Group from $76.00 to $85.00 and gave the stock an “overweight” rating in a research note on Monday, January 6th. Five investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Unum Group has a consensus rating of “Moderate Buy” and an average price target of $75.45.

Insiders Place Their Bets

In other Unum Group news, CEO Richard P. Mckenney sold 58,865 shares of the business’s stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $75.39, for a total transaction of $4,437,832.35. Following the transaction, the chief executive officer now owns 1,007,003 shares in the company, valued at $75,917,956.17. The trade was a 5.52 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Elizabeth Claire Ahmed sold 5,000 shares of the company’s stock in a transaction dated Thursday, October 31st. The stock was sold at an average price of $64.16, for a total value of $320,800.00. Following the completion of the sale, the executive vice president now directly owns 58,741 shares of the company’s stock, valued at $3,768,822.56. The trade was a 7.84 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 107,914 shares of company stock worth $7,998,745 over the last ninety days. 0.93% of the stock is owned by company insiders.

Unum Group Trading Up 0.4 %

UNM stock opened at $73.26 on Thursday. Unum Group has a 52 week low of $44.83 and a 52 week high of $77.63. The company has a market cap of $13.38 billion, a price-to-earnings ratio of 7.93, a PEG ratio of 0.97 and a beta of 0.81. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 0.32. The business has a fifty day simple moving average of $73.39 and a 200-day simple moving average of $62.56.

Unum Group (NYSE:UNM) last released its quarterly earnings data on Tuesday, October 29th. The financial services provider reported $2.13 EPS for the quarter, topping analysts’ consensus estimates of $2.10 by $0.03. The company had revenue of $3.22 billion for the quarter, compared to the consensus estimate of $3.26 billion. Unum Group had a return on equity of 15.21% and a net margin of 13.76%. During the same period last year, the business posted $1.94 EPS. The company’s quarterly revenue was up 4.0% compared to the same quarter last year. On average, equities research analysts expect that Unum Group will post 8.54 EPS for the current year.

Unum Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Friday, January 24th will be given a dividend of $0.42 per share. The ex-dividend date is Friday, January 24th. This represents a $1.68 dividend on an annualized basis and a yield of 2.29%. Unum Group’s dividend payout ratio (DPR) is 18.18%.

About Unum Group

Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.